Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	786.07	776.05	857.93	932.6	983.1	1,622
Trading Asset Securities	-	50	50	3	-	-
Cash & Short-Term Investments	786.07	826.05	907.93	935.6	983.1	1,622
Cash Growth	3.35%	-9.02%	-2.96%	-4.83%	-39.38%	265.82%
Accounts Receivable	723.03	425.75	440.48	591.65	227.87	166.7
Other Receivables	52.43	60.68	56.94	53.54	56.96	32.73
Receivables	775.46	486.44	497.42	645.19	284.83	199.43
Inventory	2,401	3,128	2,374	2,166	1,121	731.43
Prepaid Expenses	-	14.04	12.87	-	-	-
Other Current Assets	222.08	228.09	145.79	192.89	107.8	240.93
Total Current Assets	4,185	4,683	3,938	3,939	2,497	2,793
Property, Plant & Equipment	2,349	2,597	2,687	2,644	1,901	376.87
Long-Term Investments	25.99	30.54	47.42	18.34	9.8	-
Goodwill	2,456	2,456	2,403	2,243	415.3	57.58
Other Intangible Assets	74.54	85.36	92.2	90.46	44.75	33.52
Long-Term Deferred Tax Assets	249.1	280.17	285.43	287.22	14.64	5.96
Long-Term Deferred Charges	390.82	485.3	485.93	415.89	331.86	201.18
Other Long-Term Assets	9.65	6.05	10.61	6.18	-	-
Total Assets	9,740	10,623	9,949	9,644	5,214	3,469
Accounts Payable	2,118	2,783	2,639	2,756	1,695	1,426
Accrued Expenses	125.21	184.59	216.07	281.91	105.3	111.36
Short-Term Debt	2,157	1,604	749.61	201.48	30	74.08
Current Portion of Long-Term Debt	603.52	249.74	572.5	155.19	5.41	-
Current Portion of Leases	-	389.42	423.84	422.6	378.41	-
Current Income Taxes Payable	40.05	19.77	44.93	66.87	42.42	23.9
Current Unearned Revenue	31.62	25.23	28.49	37.43	18.07	12.44
Other Current Liabilities	89.96	212.14	185.57	304.14	146.67	70.85
Total Current Liabilities	5,165	5,467	4,860	4,225	2,421	1,719
Long-Term Debt	970.89	1,190	1,022	1,192	25.23	30.64
Long-Term Leases	744.32	909.27	927.52	963.28	842.93	-
Long-Term Unearned Revenue	11.16	11.53	11.96	12.63	13.06	8.51
Long-Term Deferred Tax Liabilities	223.07	265.03	282.25	275.44	19.03	8.9
Other Long-Term Liabilities	-	-	-	407.82	-	-
Total Liabilities	7,115	7,843	7,104	7,076	3,321	1,767
Common Stock	154.54	156.66	128.85	99.16	69.53	53
Additional Paid-In Capital	1,338	1,397	1,361	1,391	1,009	985.9
Retained Earnings	1,279	1,341	1,379	1,109	856.89	678.26
Treasury Stock	-145.44	-97.81	-7.15	-14.78	-25.75	-
Comprehensive Income & Other	0.06	0.12	-	-	-	-
Total Common Equity	2,626	2,797	2,861	2,585	1,910	1,717
Minority Interest	-1.31	-16.68	-16.51	-16.59	-16.72	-15.45
Shareholders' Equity	2,625	2,781	2,845	2,568	1,893	1,702
Total Liabilities & Equity	9,740	10,623	9,949	9,644	5,214	3,469
Total Debt	4,476	4,342	3,696	2,935	1,282	104.72
Net Cash (Debt)	-3,690	-3,516	-2,788	-1,999	-298.88	1,517
Net Cash Growth	-	-	-	-	-	297.22%
Net Cash Per Share	-23.94	-22.78	-18.03	-13.17	-2.14	13.19
Filing Date Shares Outstanding	148.16	154.49	154.62	154.69	141	139.73
Total Common Shares Outstanding	148.16	154.49	154.62	154.69	141	139.73
Working Capital	-980.66	-784.78	-922.54	-285.78	76	1,075
Book Value Per Share	17.72	18.11	18.50	16.71	13.54	12.29
Tangible Book Value	95.27	255.83	365.8	251.51	1,450	1,626
Tangible Book Value Per Share	0.64	1.66	2.37	1.63	10.28	11.64
Buildings	-	906.25	902.64	891.8	369.39	358.62
Machinery	-	312.13	277.99	225.09	158.25	119.01
Construction In Progress	-	253.85	202.01	180.56	73.91	3.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.